ACE and sarcopenia: A randomized controlled trial (RCT; EudraCT # 2014‐003455‐61; Active) in 440 patients aged 70 years and over with sarcopenia will determine the efficacy of supplementation with the amino acid leucine and/or perindopril (ACE inhibitor) to potentially improve muscle mass and function in people with sarcopenia.39